Research Use Only — Age Verification

The products on this site are sold strictly for laboratory and research use only. They are not for human or animal consumption and are not drugs, supplements, or medical devices. By entering, you confirm that you are at least 21 years of age and a qualified researcher or authorized representative of a research entity, that you are purchasing solely for lawful research-use-only purposes, and that you agree to our Terms and Research-Use Disclaimer. You accept sole responsibility for complying with all applicable laws in your jurisdiction. If you do not meet these requirements or do not agree, please exit.

Email is optional. Add it for 15% off your first order — or just tap Enter below. We'll never sell or share it.

🔬 Third-party tested by independent US labs — Certificate of Analysis available  ·  Inventory updated regularly  ·  Wholesale pricing available on request
NovaForge Labs
AccountHi, Welcome
Browse all research materials →
Tesamorelin 10mg lyophilized research peptide vial, NovaForge Labs

Tesamorelin 10mg

Lyophilized · reserved for qualified in-vitro laboratory research

Looking for more laboratory research materials?
Browse the full catalog →

General information & research context

Tesamorelin is a growth-hormone-releasing-hormone (GHRH) analogue supplied as a 10mg lyophilized powder in a sealed vial for qualified in-vitro laboratory research. Each lot is third-party HPLC-tested — this lot at 99.78% purity — with a lot-specific Certificate of Analysis, and reconstitutes with bacteriostatic water. Not for human or animal consumption. Research use only.

Tesamorelin at a glance

Synonymtrans-3-hexenoyl GHRH (1-44) amide
Molecular formulaC221H366N72O67S
Average molecular weight5136 g/mol
CAS number218949-48-5
PubChem CID16137828
FormLyophilized powder, 10mg per vial
Purity (current lot)99.78% (HPLC, third-party)

Lot certificate summary

Tesamorelin 10mg COA summary: lot NFL-0002, 99.82% HPLC purity, Freedom Diagnostics
Lot NFL-0002 · 99.82% HPLC · Freedom Diagnostics
Tesamorelin 10mg COA summary: lot Lot - TSM - QSCT1, 99.78% HPLC purity, ILS Laboratories
Lot Lot - TSM - QSCT1 · 99.78% HPLC · ILS Laboratories

Each card summarizes the independent lab report for a lot currently in stock. Look up your own lot on the lot verification page.

What tesamorelin is as a molecule

Tesamorelin is a synthetic analogue of human growth hormone-releasing hormone (GHRH). It keeps the full 44-residue GHRH sequence and adds a trans-3-hexenoyl group at the N-terminus, which is why reference databases list it as trans-3-hexenoyl GHRH (1-44) amide. At roughly 5.1 kDa it is one of the larger peptides in the GH-axis research category.

The molecule is also the active ingredient of Egrifta, a prescription drug approved by the US FDA. That regulatory history means tesamorelin has an unusually deep clinical and pharmacological literature for a GHRH analogue, which makes it a useful comparator when researchers study how modified GHRH peptides behave. The material on this page is a research reference material supplied for qualified in-vitro laboratory work. It is not Egrifta, is not a drug product, and is not intended for people or animals.

What the published research covers

As regulatory background, tesamorelin is the active ingredient of Egrifta, a licensed drug product that the FDA approved in November 2010 for an indication in HIV-associated lipodystrophy [1]. That approval applies to the licensed drug product only, not to research reference material such as this. A 2011 review describes it as a GHRH analogue that stimulates the synthesis and release of the body's own growth hormone, rather than supplying growth hormone directly [2].

Most clinical data come from two phase 3 placebo-controlled trials. A pooled analysis of 806 participants with HIV used computed tomography to measure visceral adipose tissue as the primary outcome and also tracked IGF-I, lipids and glucose parameters over 26 weeks with a 26-week extension [3].

Work outside metabolism exists as well. A randomized substudy in 30 adults aged 55 to 87, some with mild cognitive impairment, used magnetic resonance spectroscopy to measure brain GABA, glutamate and related metabolites after 20 weeks of tesamorelin or placebo [4]. These are all clinical studies of the approved drug under medical supervision. They describe the compound's biology and are not evidence about any research-grade material.

Summaries describe published laboratory and clinical literature for context only. NovaForge Labs materials are sold strictly for in-vitro research and are not intended for human or animal use.

Independent testing for this product

In addition to the per-lot certificate of analysis, NovaForge submitted tesamorelin lot NFL-0002 to Finnrick through its Launch testing program (vendor-submitted). Finnrick reported identity confirmed and HPLC purity of 99.7% and 99.5% on two vials (October 2026). Net content for that lot was 10.56mg per vial on Freedom Diagnostics COA Nova2608180230. The current lot measured 99.78% by HPLC.

Laboratory handling notes

As a large lyophilized peptide, tesamorelin is best kept sealed, dry and frozen or refrigerated, away from light. Let the vial reach room temperature before opening so moisture does not condense on the cake. Once a solution is prepared for an assay, keep it cold, divide it into single-use aliquots and avoid repeated freeze-thaw cycles, which can degrade long peptide chains.

Tesamorelin FAQ

Is this product the same as Egrifta?

No. Egrifta is an FDA-approved prescription drug manufactured and labeled for patient care. Our tesamorelin is a research reference material sold for qualified in-vitro laboratory research only. It shares the active peptide's identity but is not a drug product and is not intended for human or animal use.

How does tesamorelin differ from sermorelin?

Sermorelin corresponds to the first 29 residues of GHRH, while tesamorelin covers the full 44-residue sequence and carries a trans-3-hexenoyl group at the N-terminus. The added length and modification give it a different molecular weight and analytical profile, which matters when you set up chromatography or mass spectrometry.

How is the purity of this lot verified?

Each lot is tested by an independent laboratory using HPLC for purity and an identity test (LC-MS or an HPLC match against a reference standard, depending on the lab). This lot measured 99.78%. The lot number appears in your order-confirmation email, and you can enter it on our lot-verification page to view the matching certificate of analysis.

Which research areas use tesamorelin as a reference compound?

It appears in endocrine and GH-axis pharmacology, in studies comparing GHRH analogues, and in analytical chemistry work such as anti-doping method development. Its published clinical record also makes it a common benchmark when labs characterize newer GHRH-derived peptides in vitro.

Where does this tesamorelin ship?

We ship to addresses in the United States with tracking, in discreet packaging with no product details on the exterior. Domestic orders typically arrive within a few business days of shipment.

What is the amino acid sequence of tesamorelin?

Tesamorelin is the full 44-residue human GHRH sequence, YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL, with a C-terminal amide and a trans-3-hexenoyl group on the N-terminal tyrosine. That modification distinguishes it from native GHRH(1-44).

References

  1. Grunfeld C, Dritselis A, Kirkpatrick P. Tesamorelin. Nat Rev Drug Discov. 2011. PubMed 21283099
  2. Dhillon S. Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy. Drugs. 2011. PubMed 21668043
  3. Falutz J, Mamputu JC, Potvin D, et al. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. J Clin Endocrinol Metab. 2010. PubMed 20554713
  4. Friedman SD, Baker LD, Borson S, et al. Growth hormone-releasing hormone effects on brain gamma-aminobutyric acid levels in mild cognitive impairment and healthy aging. JAMA Neurol. 2013. PubMed 23689947

Handling & storage

Store lyophilized material in a cool, dry place away from light. For long-term storage, store at -20°C. Once reconstituted in solution for laboratory use, refrigerate at 2–8°C and use within the appropriate timeframe. Handle only in an appropriate laboratory setting by personnel trained in the safe handling of research chemicals.

Research use notice

For in-vitro laboratory research use only. Not for human or animal consumption. Not a drug, dietary supplement, food, cosmetic, or medical device. Not evaluated or approved by the FDA or any regulatory authority for safety or efficacy in humans or animals. By purchasing, you confirm you are 21 years of age or older and a qualified researcher (or authorized representative of a research entity) purchasing solely for lawful in-vitro laboratory research. See our Terms & Research-Use Disclaimer. See our Research Use Agreement.

Shipping information

We ship Monday–Friday with a 1:00 PM PST cutoff; orders with confirmed payment before the cutoff ship the same business day. Orders ship in a plain black bubble mailer with tracking, with no product details on the outside. Free shipping on orders over $200. All sales are final — refunds or exchanges only if purity is below 99%. See our full Shipping & Returns Policy.

Researcher reviews

Leave a review
Rate your sourcing experience — quality, COA accuracy, shipping, packaging. Please keep it to your research-supply experience; reviews describing any human or animal use can’t be published.
☆☆☆☆☆
Welcome back

15% off your next order

Order 2 or more items and get 20% off instead.

BACK15
Save to your wishlist ♡

Enter your email and we'll alert you the moment it's back in stock — plus the occasional offer. No spam, unsubscribe anytime.